Dr. Den is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 S 11th St
Bodine Center
Philadelphia, PA 19107Phone+1 215-955-6702Fax+1 215-955-5331
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Radiation Oncology, 2007 - 2011
Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2007
Harvard Medical SchoolClass of 2007
Certifications & Licensure
PA State Medical License 2007 - 2024
NJ State Medical License 2017 - 2023- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer Start of enrollment: 2011 Sep 22
- Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer Start of enrollment: 2012 May 01
- High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2012 Oct 04
- Join now to see all
Publications & Presentations
PubMed
- 102 citationsA Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer.Neil K. Jairath, Alan Dal Pra, Randy Vince, Robert T. Dess, William C. Jackson
European Urology. 2021-03-01 - 75 citationsRacial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location.Farzana A. Faisal, Debasish Sundi, Jeffrey J. Tosoian, Voleak Choeurng, Mohammed Alshalalfa
European Urology. 2016-07-01 - 131 citationsDevelopment and validation of a novel integrated clinical-genomic risk group classification for localized prostate cancerDaniel E. Spratt, Jingbin Zhang, Maria Santiago-Jimenez, Robert T. Dess, John W. Davis
Journal of Clinical Oncology. 2017-11-29
Journal Articles
- Tumor Cell Heterogeneity and Resistance; Report from the 2018 Coffey‐Holden Prostate Cancer Academy MeetingThomas A Hope, Kenneth J Pienta, Fatima Karzai, Simpa S Salami, Robert B Den, The Prostate
- Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological FeaturesRahul D. Tendulkar, Kevin L. Stephans, Stanley L. Liauw, Robert B. Den, Shre Agrawal, Mitchel S. Anscher, Jason A. Efstathiou, Thomas M. Pisansky, Jason W. Hearn, Jef ..., JAMA
Press Mentions
Alpha Tau Treats First Patient with Recurrent Lung CancerOctober 10th, 2024- From Comfort to Cure’: Answering the Call of ASCO 2024August 16th, 2024
- Alpha Tau Announces Alpha DaRT™ Treatment of First Two Patients in Its Pivotal Multicenter Recurrent Skin Cancer (ReSTART) TrialMarch 8th, 2023
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
